VIRX - Viracta Therapeutics - Stock Forecast

Coverage Performance Price Targets & Ratings Chart Insider Trading

VIRX is currently covered by 5 analysts with an average price target of $13.39. This is a potential upside of $12.31 (1139.81%) from yesterday's end of day stock price of $1.08.

Viracta Therapeutics's activity chart (see below) currently has 7 price targets and 18 ratings on display. The stock rating distribution of VIRX is 100% BUY.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 10% with an average time for these price targets to be met of 108.8 days.

Highest price target for VIRX is $5, Lowest price target is $5, average price target is $13.39.

Most recent stock forecast was given by ROBERT BURNS from HC WAINWRIGHT on 05-Jan-2024. First documented stock forecast 08-Mar-2019.

Best performing analysts who are covering VIRX - Viracta Therapeutics:

Hartaj Singh Gregory Renza Andrew Berens Robert Burns Kennen Mackay

Currently out of the existing stock ratings of VIRX, 13 are a BUY (100%).

Analyst name

Rating

Current price target

Potential distance

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

2 months 23 days ago

0/1 (0%)

$23.98 (217.60%)

Buy

4 months 18 days ago

0/2 (0%)

$6.25 (357.14%)

Buy

4 months 18 days ago

0/1 (0%)

$7.32 (273.13%)

Buy

5

$3.92 (362.96%)

18

7 months 13 days ago

0/2 (0%)

$3.7 (284.62%)

Buy

36

1 years 1 days ago

1/2 (50%)

$20.3 (129.30%)

544

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is VIRX (Viracta Therapeutics) average time for price targets to be met?

On average it took 108.8 days on average for the stock forecasts to be realized with a an average price target met ratio 10

Which analyst has the current highest performing score on VIRX (Viracta Therapeutics) with a proven track record?

HARTAJ SINGH

Which analyst has the current lower performing score on VIRX (Viracta Therapeutics) with a proven track record?

KENNEN MACKAY

Which analyst has the most public recommendations on VIRX (Viracta Therapeutics)?

Hartaj Singh works at OPPENHEIMER and has 19 price targets and 9 ratings on VIRX

Which analyst is the currently most bullish on VIRX (Viracta Therapeutics)?

Andrew Berens with highest potential upside - $3.92

Which analyst is the currently most reserved on VIRX (Viracta Therapeutics)?

Hartaj Singh with lowest potential downside - -$0

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?